Avadel Pharmaceuticals (AVDL) Total Liabilities (2016 - 2022)
Historic Total Liabilities for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $158.2 million.
- Avadel Pharmaceuticals' Total Liabilities fell 419.91% to $158.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $158.2 million, marking a year-over-year decrease of 419.91%. This contributed to the annual value of $169.0 million for FY2021, which is 1315.52% up from last year.
- According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Total Liabilities is $158.2 million, which was down 419.91% from $161.3 million recorded in Q2 2022.
- Avadel Pharmaceuticals' 5-year Total Liabilities high stood at $264.8 million for Q1 2018, and its period low was $149.4 million during Q4 2020.
- Moreover, its 5-year median value for Total Liabilities was $169.0 million (2021), whereas its average is $178.0 million.
- In the last 5 years, Avadel Pharmaceuticals' Total Liabilities soared by 3266.48% in 2018 and then plummeted by 3081.6% in 2019.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Total Liabilities stood at $187.5 million in 2018, then decreased by 3.67% to $180.6 million in 2019, then fell by 17.31% to $149.4 million in 2020, then increased by 13.16% to $169.0 million in 2021, then fell by 6.4% to $158.2 million in 2022.
- Its last three reported values are $158.2 million in Q3 2022, $161.3 million for Q2 2022, and $165.9 million during Q1 2022.